These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
749 related items for PubMed ID: 21403086
21. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension. Lenski M, Mahfoud F, Razouk A, Ukena C, Lenski D, Barth C, Linz D, Laufs U, Kindermann I, Böhm M. Int J Cardiol; 2013 Nov 30; 169(6):418-24. PubMed ID: 24157238 [Abstract] [Full Text] [Related]
23. Transradial renal denervation for the treatment of resistant hypertension. Dong H, Jiang X, Liang T, Zou Y, Guan T, Peng M, Song L, Zhang H, Wu H, Xu B, Yang Y, Gao R. J Invasive Cardiol; 2014 Jul 30; 26(7):322-7. PubMed ID: 24993989 [Abstract] [Full Text] [Related]
25. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program. Khan NA, Herman RJ, Quinn RR, Rabkin SW, Ravani P, Tobe SW, Feldman RD, Wijeysundera HC, Padwal RS, Canadian Hypertension Education Program. Can J Cardiol; 2014 Jan 30; 30(1):16-21. PubMed ID: 24269056 [Abstract] [Full Text] [Related]
27. Transcatheter Alcohol-Mediated Perivascular Renal Denervation With the Peregrine System: First-in-Human Experience. Fischell TA, Ebner A, Gallo S, Ikeno F, Minarsch L, Vega F, Haratani N, Ghazarossian VE. JACC Cardiovasc Interv; 2016 Mar 28; 9(6):589-98. PubMed ID: 27013159 [Abstract] [Full Text] [Related]
28. Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension. Hering D, Marusic P, Walton AS, Duval J, Lee R, Sata Y, Krum H, Lambert E, Peter K, Head G, Lambert G, Esler MD, Schlaich MP. Int J Cardiol; 2016 Jan 01; 202():388-93. PubMed ID: 26432488 [Abstract] [Full Text] [Related]
30. Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system. Tsioufis CP, Papademetriou V, Dimitriadis KS, Kasiakogias A, Tsiachris D, Worthley MI, Sinhal AR, Chew DP, Meredith IT, Malaiapan Y, Thomopoulos C, Kallikazaros I, Tousoulis D, Worthley SG. Int J Cardiol; 2015 Dec 15; 201():345-50. PubMed ID: 26301677 [Abstract] [Full Text] [Related]
31. Renal denervation in moderate treatment-resistant hypertension. Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE. J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901 [Abstract] [Full Text] [Related]
32. Ultra-long-term efficacy and safety of catheter-based renal denervation in resistant hypertension: 10-year follow-up outcomes. Al Ghorani H, Kulenthiran S, Lauder L, Recktenwald MJM, Dederer J, Kunz M, Götzinger F, Ewen S, Ukena C, Böhm M, Mahfoud F. Clin Res Cardiol; 2024 Oct 12; 113(10):1384-1392. PubMed ID: 38451261 [Abstract] [Full Text] [Related]
33. The effect of two different renal denervation strategies on blood pressure in resistant hypertension: Comparison of full-length versus proximal renal artery ablation. Chen W, Ling Z, Du H, Song W, Xu Y, Liu Z, Su L, Xiao P, Yuan Y, Lu J, Zhang J, Li Z, Shao J, Zhong B, Zhou B, Woo K, Yin Y. Catheter Cardiovasc Interv; 2016 Nov 12; 88(5):786-795. PubMed ID: 27219520 [Abstract] [Full Text] [Related]